Teva Strikes $100M Deal, Ends Rhode Island Opioid Trial
The Rhode Island attorney general on Monday announced a settlement with Teva Pharmaceuticals and several of its affiliates worth about $100 million, including $21 million in cash in addition to drug...To view the full article, register now.
Already a subscriber? Click here to view full article